Design
Review
Authors
Loading...
Highlights PVAT as a potential cardiometabolic modulator; leaves open whether targeting it improves clinical outcomes.
Key points are not available for this paper at this time.
Eringa et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: